Streptolysin O enhances keratinocyte migration and proliferation and promotes skin organ culture wound healing in vitro

Wound Repair and Regeneration

Volumn 15, Issue 1, 2007, Pages 71-79

  Tomic Canic, Marjana ^a,d   Mamber, Stephen W ^b   Stojadinovic, Olivera ^a,c   Lee, Brian ^a,d   Radoja, Nadezda ^a,e   McMichael, John ^b  

^a NEW YORK UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b Beech Tree Labs   (United States)

^c HOSPITAL FOR SPECIAL SURGERY   (United States)

^d GENENTECH INC   (United States)

^e NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ML 05; STREPTOLYSIN O; UNCLASSIFIED DRUG;

ARTICLE; CELL MIGRATION; CELL PROLIFERATION; CELL STIMULATION; CONTROLLED STUDY; CULTURE MEDIUM; DOSE RESPONSE; EPITHELIZATION; FIBROBLAST; HUMAN; HUMAN CELL; HUMAN TISSUE; IN VITRO STUDY; KERATINOCYTE; PRIORITY JOURNAL; SKIN CULTURE; WOUND; WOUND HEALING;

BACTERIAL PROTEINS; CELL CULTURE TECHNIQUES; CELL MOVEMENT; CELL PROLIFERATION; FIBROBLASTS; HUMANS; KERATINOCYTES; ORGAN CULTURE TECHNIQUES; SKIN; STREPTOLYSINS; WOUND HEALING; WOUNDS, PENETRATING;

EID: 33846448746     PISSN: 10671927     EISSN: 1524475X     Source Type: Journal    
DOI: 10.1111/j.1524-475X.2006.00187.x     Document Type: Article

References (52)

1. Johnson MK, Geoffroy C, Alouf JE. Binding of cholesterol by sulfhydryl-activated cytolysins. Infect Immun 1980; 27: 97-101.
2. Alouf JE, Geoffroy C, Pattus F, Verger R. Surface properties of bacterial sulfhydryl-activated cytolytic toxins. Interaction with monomolecular films of phosphatidylcholine and various sterols. Eur J Biochem 1984; 141: 205-10.
3. Bhakdi S, Tranum-Jensen J, Sziegoleit A. Mechanism of membrane damage by streptolysin-O. Infect Immun 1985; 47: 52-60.
4. Palmer M. The family of thiol-activated, cholesterol-binding cytolysins. Toxicon 2001; 39: 1681-9.
5. McMichael J. Methods for treatment of scar tissue. United States Patent 5,736,508, 1998
6. Mamber SW, Long V, Rhodes RG, Pond-Tor S, Wheeler LR, Fredericks K, Vanscoy B, Sauniere J-F, Steinschneider R, Laurent J-C, McMichael J. The use of streptolysin O for the treatment of scars, adhesions and fibrosis: initial investigations using murine models of scleroderma. Nonlinear Biol Toxicol Med 2004; 2: 67-87.
7. McMichael J. Methods for treating motor deficits. United States Patent, 5,576,289, 1996.
8. Nedelec B, Ghahary A, Scott PG, Tredget EE. Control of wound contraction. Basic and clinical features. Hand Clin 2000; 16: 289-302.
9. Haverstock BD. Hypertrophic scars and keloids. Clin Podiatr Med Surg 2001; 18: 147-59.
10. Azouz A, Razzaque MS, El-Hallak M, Taguchi T. Immunoinflammatory responses and fibrogenesis. Med Electron Microsc 2004; 37: 141-8.
11. Bellemare J, Roberge CJ, Bergeron D, Lopez-Valle CA, Roy M, Moulin VJ. Epidermis promotes dermal fibrosis: role in the pathogenesis of hypertrophic scars. J Pathol 2005; 206: 1-8.
12. Houldsworth S, Andrew PW, Mitchell TJ. Pneumolysin stimulates production of tumor necrosis factor alpha and interleukin-1 beta by human mononuclear phagocytes. Infect Immun 1994; 62: 1501-3.
13. Kraakman EM, Bontrop RE, Groenestein R, Jonker M, Haaijman JJ, Hart BA. Characterization of the natural immune response of rhesus monkey CD4+ve T cells to the bacterial antigen streptolysin O (SLO). J Med Primatol 1995; 24: 306-12.
14. Baba H, Kawamura I, Kohda C, Nomura T, Ito Y, Kimoto T, Watanabe I, Ichiyama S, Mitsuyama M. Induction of gamma interferon and nitric oxide by truncated pneumolysin that lacks pore-forming activity. Infect Immun 2002; 70: 107-13.
15. Cockeran R, Durandt C, Feldman C, Mitchell TJ, Anderson R. Pneumolysin activates the synthesis and release of interleukin-8 by human neutrophils in vitro. J Infect Dis 2002; 186: 562-5.
16. Kadioglu A, Coward W, Colston MJ, Hewitt CR, Andrew PW. CD4-T-lymphocyte interactions with pneumolysin and pneumococci suggest a crucial protective role in the host response to pneumococcal infection. Infect Immun 2004; 72: 2689-97.
17. Granstein RD, Murphy GF, Margolis RJ, Byrne MH, Amento EP. Gamma-interferon inhibits collagen synthesis in vivo in the mouse. J Clin Invest 1987; 79: 1254-8.
18. Granstein RD, Flotte TJ, Amento EP. Interferons and collagen production. J Invest Dermatol 1990; 95 (Suppl. 6): 75S-80S.
19. Shi Z, Wakil AE, Rockey DC. Strain-specific differences in mouse hepatic wound healing are mediated by divergent T helper cytokine responses. Proc Natl Acad Sci USA 1997; 94: 10663-8.
20. Ishida Y, Kondo T, Takayasu T, Iwakura Y, Mukaida N. The essential involvement of cross-talk between IFN-gamma and TGF-beta in the skin wound-healing process. J Immunol 2004; 172: 1848-55.
21. Aruffo A, Stamenkovic I, Melnick M, Underhill CB, Seed B. CD44 is the principal cell surface receptor for hyaluronate. Cell 1990; 61: 1303-13.
22. Lesley J, Hyman R, Kincade PW. CD44 and its interaction with extracellular matrix. Adv Immunol 1993; 54: 271-335.
23. Cichy J, Pure E. The liberation of CD44. J Cell Biol 2003; 161: 839-43.
24. Rilla K, Lammi MJ, Sironen R, Torronen K, Luukkonen M, Hascall VC, Midura RJ, Hyttinen M, Pelkonen J, Tammi M, Tammi R. Changed lamellipodial extension, adhesion plaques and migration in epidermal keratinocytes containing constitutively expressed sense and antisense hyaluronan synthase 2 (Has2) genes. J Cell Sci 2002; 115: 3633-43.
25. Karvinen S, Pasonen-Seppanen S, Hyttinen JM, Pienimaki JP, Torronen K, Jokela TA, Tammi MI, Tammi R. Keratinocyte growth factor stimulates migration and hyaluronan synthesis in the epidermis by activation of keratinocyte hyaluronan synthases 2 and 3. J Biol Chem 2003; 278: 49495-504.
26. Tammi R, Pasonen-Seppanen S, Kolehmainen E, Tammi M. Hyaluronan synthase induction and hyaluronan accumulation in mouse epidermis following skin injury. J Invest Dermatol 2005; 124: 898-905.
27. Johnson MK, Gebhardt BM, Berman MB. Appearance of collagenase in pneumolysin-treated corneal fibroblast cultures. Curr Eye Res 1988; 7: 951-3.
28. Arakawa M, Hatamochi A, Mori Y, Mori K, Ueki H, Moriguchi T. Reduced collagenase gene expression in fibroblasts from hypertrophic scar tissue. Br J Dermatol 1996; 134: 863-8.
29. Randolph RK, Simon M. Characterization of retinol metabolism in cultured human epidermal keratinocytes. J Biol Chem 1993; 268: 9198-205.
30. Radoja N, Komine M, Jho SH, Blumenberg M, Tomic-Canic M. Novel mechanism of steroid action in skin through glucocorticoid receptor monomers. Mol Cell Biol 2000; 20: 4328-39.
31. Lee B, Vouthounis C, Stojadinovic O, Brem H, Im M, Tomic-Canic M. From an enhanceosome to a repressosome: molecular antagonism between glucocorticoids and EGF leads to inhibition of wound healing. J Mol Biol 2005; 345: 1083-97.
32. Stojadinovic O, Brem H, Vouthounis C, Lee B, Fallon J, Stallcup M, Merchant A, Galiano RD, Tomic-Canic M. Molecular pathogenesis of chronic wounds: the role of beta-catenin and c-myc in the inhibition of epithelialization and wound healing. Am J Pathol 2005; 167: 59-69.
33. Zavadil J, Cermak L, Soto-Nieves N, Bottinger EP. Integration of TGF-beta/Smad and Jagged1/Notch signalling in epithelial-to-mesenchymal transition. EMBO J 2004; 23: 1155-65.
34. Nasca MR, O'Toole EA, Palicharla P, West DP, Woodley DT. Thalidomide increases human keratinocyte migration and proliferation. J Invest Dermatol 1999; 113: 720-4.
35. Woodley DT, Chen JD, Kim JP, Sarret Y, Iwasaki T, Kim YH, O'Keefe EJ. Re-epithelialization. Human keratinocyte locomotion. Dermatol Clin 1993; 11: 641-6.
36. Santoro MM, Gaudino G. Cellular and molecular facets of keratinocyte reepithelization during wound healing. Exp Cell Res 2005; 304: 274-86.
37. Falanga V, Isaacs C, Paquette D, Downing G, Kouttab N, Butmarc J, Badiavas E, Hardin-Young J. Wounding of bioengineered skin: cellular and molecular aspects after injury. J Invest Dermatol 2002; 119: 653-60.
38. Calabrese EJ, Baldwin LA. Hormesis: the dose-response revolution. Annu Rev Pharmacol Toxicol 2003; 43: 175-97.
39. Kischer CW. The microvessels in hypertrophic scars, keloids and related lesions: a review. J Submicrosc Cytol Pathol 1992; 24: 281-96.
40. Varga J, Jimenez SA. Modulation of collagen gene expression: its relation to fibrosis in systemic sclerosis and other disorders. Ann Intern Med 1995; 122: 60-2.
41. Van Epps DE, Andersen BR. Streptolysin O inhibition of neutrophil chemotaxis and mobility: nonimmune phenomenon with species specificity. Infect Immun 1974; 9: 27-33.
42. Paton JC, Ferrante A. Inhibition of human polymorphonuclear leukocyte respiratory burst, bactericidal activity, and migration by pneumolysin. Infect Immun 1983; 41: 1212-6.
43. Johnson MK, Boese-Marrazzo D, Pierce WA Jr. Effects of pneumolysin on human polymorphonuclear leukocytes and platelets. Infect Immun 1981; 34: 171-6.
44. Gillitzer R, Goebeler M. Chemokines in cutaneous wound healing. J Leukoc Biol 2001; 69: 513-21.
45. Theilgaard-Monch K, Knudsen S, Follin P, Borregaard N. The transcriptional activation program of human neutrophils in skin lesions supports their important role in wound healing. J Immunol 2004; 172: 7684-93.
46. Schaller M, Boeld U, Oberbauer S, Hamm G, Hube B, Korting HC. Polymorphonuclear leukocytes (PMNs) induce protective Th1-type cytokine epithelial responses in an in vitro model of oral candidosis. Microbiology 2004; 150: 2807-13.
47. Borregaard N, Theilgaard-Monch K, Cowland JB, Stahle M, Sorensen OE. Neutrophils and keratinocytes in innate immunity - cooperative actions to provide antimicrobial defense at the right time and place. J Leukoc Biol 2005; 77: 439-43.
48. Maas-Szabowski N, Stark HJ, Fusenig NE. Keratinocyte growth regulation in defined organotypic cultures through IL-1-induced keratinocyte growth factor expression in resting fibroblasts. J Invest Dermatol 2000; 114: 1075-84.
49. Rennekampff HO, Hansbrough JF, Kiessig V, Dore C, Sticherling M, Schroder JM. Bioactive interleukin-8 is expressed in wounds and enhances wound healing. J Surg Res 2000; 93: 41-54.
50. Sugawara T, Gallucci RM, Simeonova PP, Luster MI. Regulation and role of interleukin 6 in wounded human epithelial keratinocytes. Cytokine 2001; 15: 328-36.
51. Satish L, Yager D, Wells A. Glu-Leu-Arg-negative CXC chemokine interferon gamma inducible protein-9 as a mediator of epidermal-dermal communication during wound repair. J Invest Dermatol 2003; 120: 1110-7.
52. Cichy J, Bals R, Potempa J, Mani A, Pure E. Proteinase-mediated release of epithelial cell-associated CD44. Extracellular CD44 complexes with components of cellular matrices. J Biol Chem 2002; 277: 44440-7.